Dr. Teitelbaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 convention Center Boulevard
South Tower 10
Philadelphia, PA 19104Phone+1 215-662-6319Fax+1 215-662-2432
Summary
- Dr. Ursina Teitelbaum is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, and UPMC Presbyterian. She received her medical degree from University of Maryland School of Medicine and has been in practice 18 years. She also speaks multiple languages, including German and French. She is experienced in medical oncology, palliative medicine and geriatrics. Her subspecialty is gastrointestinal oncology.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2003 - 2005
- University of ChicagoFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003
- University of ChicagoResidency, Internal Medicine, 1999 - 2002
- University of Maryland School of MedicineClass of 1999
Certifications & Licensure
- PA State Medical License 2006 - 2024
- IL State Medical License 1999 - 2008
Awards, Honors, & Recognition
- Deenie Greitzer and Daniel G Haller Associate Professorship University of Pennsylvania, 2015-2016
- Academy of Master Clinicians University of Pennsylvania, 2014-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer Start of enrollment: 2010 Sep 01
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 19 citationsOmission of adjuvant therapy after gastric cancer resection: development of a validated risk model.Jashodeep Datta, Matthew T. McMillan, Eric K. Shang, Ronac Mamtani, Russell S. Lewis
Journal of the National Comprehensive Cancer Network. 2015-05-01 - 40 citationsFluoropyrimidine-induced cardiac toxicity: challenging the current paradigm.Suparna C. Clasen, Bonnie Ky, Rupal O'Quinn, Bruce Giantonio, Ursina R. Teitelbaum
Journal of Gastrointestinal Oncology. 2017-12-01 - 1222 citationsCD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and HumansGregory L. Beatty, Elena G. Chiorean, Matthew P. Fishman, Babak Saboury, Ursina R. Teitelbaum
Science. 2011-03-25
Press Mentions
- For Alex Trebek, the Toughest Question: Can He Face down Pancreatic Cancer?March 7th, 2019
- Alex Trebek Has Stage 4 Pancreatic Cancer. Here's What That MeansMarch 7th, 2019
- The Future of Pancreatic Cancer: A Conversation with Medical Oncologist Mark O'Hara, MDFebruary 11th, 2019
- Join now to see all
Other Languages
- German, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: